Skip to main content
. Author manuscript; available in PMC: 2018 Jul 9.
Published in final edited form as: Eur Radiol. 2017 Nov 24;28(6):2255–2263. doi: 10.1007/s00330-017-5154-8

Table 1.

The demographic summary of patients enrolled into this study. All data in the table are out of 84 patients, with 3 patients excluded due to the lack of documented radiation data.

All patients (n = 84) Necrosis Patients (n= 19) Non-necrosis Patients (n=65)
Gender
 Male 46 7 39
 Female 38 12 26
Number Alive 12 3 9
Age at SRS (years) 28–79 37–71 28–79
Primary Histology
 Lung 21 5 16
 Melanoma 42 8 34
 Renal 5 2 3
 Breast 10 3 7
 Other 6 1 5
Prior WBRT 22 7 15
Chemotherapy prior to SRS 61 13 48
Chemotherapy after SRS 37 11 26
Interval between SRS and resection (days) 267 (48–1307) 258 (102–1307) 26 (48–920)
Median (range)
SRS Radiation Dose (Gy) 20 (13–24)* 18 (14–22) 20 (13–24)
Median (range)
Prior SRS 9 1 8
*

Out of 81 patients, with 6 patients excluded due to the lack of documented radiation dose.